Cancer Research Horizons has appointed Jonathan Tobin and Genghis Lloyd-Harris as advisory investors-in-residence in its ventures team.Pharma
IDH Group: Dr Julian Perry
Integrated Dental Holdings (IDH) has appointed Dr Julian Perry as group commercial director, starting 1 January 2018.
Perry joins from Oasis Dental Care, now part of Bupa, where he held roles including group clinical director and director of acquisitions. He has more than twenty years’ experience within multi-site dentistry, and continues to be a practicing clinician.
Tom Riall, IDH chief executive, commented: “I am delighted to welcome Julian to the IDH team. As a practising clinician with 20 years’ experience in multi-site dentistry and more than six years on the leadership team of Oasis Dental Care, Julian will bring unrivalled commercial experience and skill to help mydentist continue to strengthen its market leading position.”
Perry commented: “Mydentist is a great brand with some outstanding clinicians and a clear plan to build on its past success. I’m looking forward to supporting this growth, working closely with my dental colleagues to help build a strong business that delivers on its NHS commitments and provides the highest quality and affordable private care.”